IP Library Granted Patent US 6,913,919
Granted Patent B2
US 6,913,919 · App. 09/991,181 · Granted Jul 5, 2005

Secreted and transmembrane polypeptides and nucleic acids encoding the same

Assignee: Genetech, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,913,919
App. No.
09/991,181
Granted
Jul 5, 2005
Kind
B2
Abstract

The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Claims (21)

1. An isolated nucleic acid comprising:

(a) the nucleic acid sequence of SEQ ID NO: 193;

(b) the full-length coding sequence of the nucleic acid sequence of SEQ ID NO:193; or

(c) the full-length coding sequence of the cDNA deposited under ATCC accession number 209977.

2. The isolated nucleic acid of claim 1 comprising the nucleic acid sequence of SEQ ID NO:193.

3. The isolated nucleic acid of claim 1 comprising the full-length coding sequence of the nucleic acid sequence of SEQ ID NO:193.

4. The isolated nucleic acid of claim 1 comprising the full-length coding sequence of the cDNA deposited under ATCC accession number 209977.

5. A vector comprising the nucleic acid of claim 1 .

6. The vector of claim 5 , wherein said nucleic acid is operably linked to control sequences recognized by a host cell transformed with the vector.

7. A host cell comprising the vector of claim 5 .

8. The host cell of claim 7 , wherein said cell is a CHO cell, an E. coli or a yeast cell.

9. An isolated nucleic acid molecule consisting of a fragment of the nucleic acid sequence of SEQ ID NO: 193, or a complement thereof, of at least 20 nucleotides length that hybridizes under stringent conditions to:

(a) the nucleic acid sequence of SEQ ID NO:193 or a complement thereof;

(b) the full-length coding sequence of the cDNA deposited under ATCC accession number 209977 or a complement thereof;

wherein, said stringent conditions use 50% formamide, 5×SSC, 50 mM sodium phosphate (pH 6.8), 0.1% sodium pyrophosphate, 5×Denhardt's solution, sonicated salmon sperm DNA (50 μg/ml), 0.1% SDS, and 10% dextran sulfate at 42° C., and washes at 42° C. in 0.2×SSC, at 55° C. in 50% formamide followed by a high-stringency wash at 55° C. in 0.1×SSC, EDTA; wherein said isolated nucleic acid molecule is suitable for use as a PCR primer or probe.

10. The isolated nucleic acid molecule of claim 9 that is at least 50 nucleotides or above in length.

11. The isolated nucleic acid molecule of claim 9 that is at least 60 nucleotides or above in length.

12. The isolated nucleic acid molecule of claim 9 that is at least 70 nucleotides or above in length.

13. The isolated nucleic acid molecule of claim 9 that is at least 80 nucleotides or above in length.

14. The isolated nucleic acid molecule of claim 9 that is at least 90 nucleotides or above in length.

15. The isolated nucleic acid molecule of claim 9 that is at least 100 nucleotides or above in length.

Continuity (6)
Continuation 0994199200 · Aug 28, 2001
Continuation PCTUS000843900 · Mar 30, 2000
Continuation In Part 0938013700
Provisional Application 6014103700 · Jun 23, 1999
Provisional Application 6008960000 · Jun 17, 1998
Related Publication 20020197615A1 · Dec 26, 2002